Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ovarian Neoplasms

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 42 articles: HTML format Text format

Single Articles

December 2017
1. OJALVO LS, Thompson ED, Wang TL, Meeker AK, et al
   Tumor-Associated Macrophages and the Tumor Immune Microenvironment of Primary and Recurrent Epithelial Ovarian Cancer (EOC).
   Hum Pathol. 2017 Dec 26. pii: S0046-8177(17)30478.
   PubMed     Text format     Abstract available
   
   
   September 2017
2. XING D, Rahmanto YS, Zeppernick F, Hannibal CG, et al
   Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.
   Hum Pathol. 2017 Sep 2. pii: S0046-8177(17)30303.
   PubMed     Text format     Abstract available
   
   
   July 2017
3. RUSSO M, Broach J, Sheldon K, Houser KR, et al
   Clonal Evolution in Paired Endometrial Intraepithelial Neoplasia/Atypical Hyperplasia and Endometrioid Adenocarcinoma.
   Hum Pathol. 2017 Jul 13. pii: S0046-8177(17)30244.
   PubMed     Text format     Abstract available
   
   
   
4. SCHOOLMEESTER JK, Moyer AM, Goodenberger ML, Keeney GL, et al
   Pathologic Findings in Breast, Fallopian Tube and Ovary Specimens in non-BRCA Hereditary Breast and/or Ovarian Cancer Syndromes: A Study of 18 Patients with Deleterious Germline Mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH or CHEK2.
   Hum Pathol. 2017 Jul 11. pii: S0046-8177(17)30240.
   PubMed     Text format     Abstract available
   
   
   April 2017
5. ROTH LM, Lyu B, Cheng L
   Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
   Hum Pathol. 2017 Apr 23. pii: S0046-8177(17)30125.
   PubMed     Text format     Abstract available
   
   
   
6. AMAN M, Ohishi Y, Imamura H, Shinozaki T, et al
   Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
   Hum Pathol. 2017 Apr 21. pii: S0046-8177(17)30123.
   PubMed     Text format     Abstract available
   
   
   
7. WANG WC, Lai YC
   Mature cystic teratomas of the ovary-reply.
   Hum Pathol. 2017 Apr 20. pii: S0046-8177(17)30118.
   PubMed     Text format    
   
   
   
8. YAMASHITA Y
   Mature cystic teratomas of the ovary.
   Hum Pathol. 2017 Apr 18. pii: S0046-8177(17)30115.
   PubMed     Text format    
   
   
   
9. KIM WY, Shim SH, Jung HY, Dong M, et al
   The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
   Hum Pathol. 2017 Apr 17. pii: S0046-8177(17)30108.
   PubMed     Text format     Abstract available
   
   
   
10. TAUBE ET, Denkert C, Sehouli J, Unger U, et al
    Cytokeratin 5/6 expression, prognosis and association with ER-alpha in high-grade serous ovarian carcinoma.
    Hum Pathol. 2017 Apr 13. pii: S0046-8177(17)30105.
    PubMed     Text format     Abstract available
    
    
    
11. HAREL-DASSA K, Yedgar S, Trope CG, Davidson B, et al
    Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.
    Hum Pathol. 2017;62:115-121.
    PubMed     Text format     Abstract available
    
    
    February 2017
12. RAWISH KR, Desouki MM, Fadare O
    Atypical Mucinous Glandular Proliferations in Endometrial Samplings: Follow-Up and Other Clinicopathologic Findings In 41 cases.
    Hum Pathol. 2017 Feb 20. pii: S0046-8177(17)30048.
    PubMed     Text format     Abstract available
    
    
    
13. BRONER EC, Trope CG, Reich R, Davidson B, et al
    TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Hum Pathol. 2017;60:180-187.
    PubMed     Text format     Abstract available
    
    
    December 2016
14. ROSSI ED, Bizzarro T, Monterossi G, Inzani F, et al
    Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30357.
    PubMed     Text format     Abstract available
    
    
    November 2016
15. PELLETIER MP, Trinh VQ, Stephenson P, Mes-Masson AM, et al
    Microcystic, elongated and fragmented (MELF) pattern invasion is mainly associated with isolated tumor cell pattern metastases in FIGO grade I endometrioid endometrial cancer (EEC).
    Hum Pathol. 2016 Nov 15. pii: S0046-8177(16)30306.
    PubMed     Text format     Abstract available
    
    
    
16. WANG Y, Li M, Meng F, Lou G, et al
    HPIP Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with epithelial ovarian cancer.
    Hum Pathol. 2016 Nov 3. pii: S0046-8177(16)30286.
    PubMed     Text format     Abstract available
    
    
    October 2016
17. ZHANG C, Sung CJ, Quddus MR, Simon RA, et al
    Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: A clinicopathologic study of 238 cases.
    Hum Pathol. 2016 Oct 13. pii: S0046-8177(16)30245.
    PubMed     Text format     Abstract available
    
    
    September 2016
18. KATO N, Kusumi T, Kamataki A, Tsunoda R, et al
    DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: A potential association with androgenic effects.
    Hum Pathol. 2016 Sep 21. pii: S0046-8177(16)30213.
    PubMed     Text format     Abstract available
    
    
    
19. SCHOLZ B, Beckert M, Mordstein V, Hohmann N, et al
    Seromucinous borderline tumor of the testis-a case report.
    Hum Pathol. 2016 Sep 2. pii: S0046-8177(16)30206.
    PubMed     Text format     Abstract available
    
    
    June 2016
20. LIANG L, Jiang Y, Chen JS, Niu N, et al
    B7-H4 Expression in Ovarian Serous Carcinoma: A Study of 306 Cases.
    Hum Pathol. 2016 Jun 24. pii: S0046-8177(16)30129.
    PubMed     Text format     Abstract available
    
    
    
21. PASCUAL-GARCIA M, Bertolo C, Nieto JC, Serrat N, et al
    CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
    Hum Pathol. 2016 Jun 23. pii: S0046-8177(16)30124.
    PubMed     Text format     Abstract available
    
    
    
22. WANG WC, Lai YC
    Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor.
    Hum Pathol. 2016;52:128-35.
    PubMed     Text format     Abstract available
    
    
    May 2016
23. LIANG L, Huang H, Dadhania V, Zhang J, et al
    Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases.
    Hum Pathol. 2016;51:96-102.
    PubMed     Text format     Abstract available
    
    
    
24. ANDRICI J, Jung J, Sheen A, D'Urso L, et al
    Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
    Hum Pathol. 2016;51:9-15.
    PubMed     Text format     Abstract available
    
    
    April 2016
25. GUPTA M, Babic A, Beck AH, Terry K, et al
    TNF-alpha expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    Hum Pathol. 2016 Apr 8. pii: S0046-8177(16)30018.
    PubMed     Text format     Abstract available
    
    
    
26. JIA W, Dong Y, Tao L, Pang L, et al
    MAP3K3 overexpression is associated with poor survival in ovarian carcinoma.
    Hum Pathol. 2016;50:162-9.
    PubMed     Text format     Abstract available
    
    
    March 2016
27. MANDATO VD, Aguzzoli L, Costagliola L, Abrate M, et al
    Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
    Hum Pathol. 2016 Mar 4. pii: S0046-8177(16)00073.
    PubMed     Text format    
    
    
    February 2016
28. LIN X, Wu BB, Xing QY, Wang SD, et al
    PAX8, auseful biomarker for ovarianserous tumors.
    Hum Pathol. 2016 Feb 19. pii: S0046-8177(16)00051.
    PubMed     Text format    
    
    
    
29. MOINUDDIN I, Bala A, Ali B, Khan H, et al
    Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Hum Pathol. 2016;48:163-6.
    PubMed     Text format     Abstract available
    
    
    October 2015
30. DAVIDSON B, Holth A, Hellesylt E, Hadar R, et al
    HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
    Hum Pathol. 2015 Oct 22. pii: S0046-8177(15)00389.
    PubMed     Text format     Abstract available
    
    
    July 2015
31. ADLER E, Mhawech-Fauceglia P, Gayther SA, Lawrenson K, et al
    PAX8 expression in ovarian surface epithelial cells.
    Hum Pathol. 2015;46:948-56.
    PubMed     Text format     Abstract available
    
    
    June 2015
32. KATZ B, Trope CG, Reich R, Davidson B, et al
    MicroRNAs in Ovarian Cancer.
    Hum Pathol. 2015 Jun 30. pii: S0046-8177(15)00218.
    PubMed     Text format     Abstract available
    
    
    
33. FATA CR, Seeley EH, Desouki MM, Du L, et al
    Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.
    Hum Pathol. 2015 Jun 23. pii: S0046-8177(15)00214.
    PubMed     Text format     Abstract available
    
    
    
34. JIANG G, Yang D, Wang L, Zhang X, et al
    A novel biomarker ARMc8 promotes the malignant progression of ovarian cancer.
    Hum Pathol. 2015 Jun 16. pii: S0046-8177(15)00209.
    PubMed     Text format     Abstract available
    
    
    
35. IMAMURA H, Ohishi Y, Aman M, Shida K, et al
    Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.
    Hum Pathol. 2015 Jun 16. pii: S0046-8177(15)00207.
    PubMed     Text format     Abstract available
    
    
    May 2015
36. ZHANG J, Tang L, Chen Y, Duan Z, et al
    Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Hum Pathol. 2015 May 30. pii: S0046-8177(15)00190.
    PubMed     Text format     Abstract available
    
    
    April 2015
37. CIUCCI A, Zannoni GF, Travaglia D, Scambia G, et al
    Mitochondrial estrogen receptor beta2 drives antiapoptotic pathways in advanced serous ovarian cancer.
    Hum Pathol. 2015 Apr 15. pii: S0046-8177(15)00120.
    PubMed     Text format     Abstract available
    
    
    
38. IWAMOTO M, Nakatani Y, Fugo K, Kishimoto T, et al
    Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Hum Pathol. 2015 Apr 11. pii: S0046-8177(15)00109.
    PubMed     Text format     Abstract available
    
    
    March 2015
39. XU B, Sun D, Wang Z, Weng H, et al
    Expression of LATS family proteins in ovarian tumors and its significance.
    Hum Pathol. 2015 Mar 5. pii: S0046-8177(15)00078.
    PubMed     Text format     Abstract available
    
    
    
40. DE KOCK L, Druker H, Weber E, Hamel N, et al
    Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    Hum Pathol. 2015 Mar 5. pii: S0046-8177(15)00074.
    PubMed     Text format     Abstract available
    
    
    February 2015
41. DESMEULES P, Trudel D, Turcotte S, Sirois J, et al
    Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
    Hum Pathol. 2015 Feb 12. pii: S0046-8177(15)00040.
    PubMed     Text format     Abstract available
    
    
    January 2015
42. CARLETON C, Houghton OP, McCluggage WG
    Juvenile granulosa cell tumor arising in ovarian adenosarcoma: an unusual form of sarcomatous overgrowth.
    Hum Pathol. 2015 Jan 7. pii: S0046-8177(15)00003.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: